PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Infectious Diseases Section, Department of Medical Specialties King Fahad Medical City, Riyadh, Saudi Arabia; College of Medicine, Alfaisal University, Riyadh, Saudi Arabia; Division of Infectious Diseases, Mayo Clinic College of Medicine and Science, Rochester, MN, USA; Division of Epidemiology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA. Electronic address: Tleyjeh.Imad@mayo.edu.\', \'Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.\', \'Division of Hematology and HSCT, Department of Oncology, King Abdulaziz Medical City, Riyadh, Saudi Arabia; King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.\', \'Department of Public Health, College of Health Sciences, Qatar University, Doha, Qatar.\', \'King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia; Department of Intensive Care, King Abdulaziz Medical City, Riyadh, Saudi Arabia.\', \'College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.\', \'Research Center, King Fahad Medical City, Riyadh, Saudi Arabia.\', \'Mayo Clinic Libraries, Mayo Clinic, Rochester, MN, USA.\', \'Department of Cardiac Sciences, King Fahad Cardiac Center, King Saud University Medical City, Riyadh, Saudi Arabia.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1198-743X(20)30690-X10.1016/j.cmi.2020.10.036
?:doi
?:hasPublicationType
?:journal
  • Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
is ?:pmid of
?:pmid
?:pmid
  • 33161150
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33161150>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33161150>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all